Related references
Note: Only part of the references are listed.Understanding the organ tropism of metastatic breast cancer through the combination of liquid biopsy tools
Lorenzo Gerratana et al.
EUROPEAN JOURNAL OF CANCER (2021)
Assessing tumor heterogeneity using ctDNA to predict and monitor therapeutic response in metastatic breast cancer
Fei Ma et al.
INTERNATIONAL JOURNAL OF CANCER (2020)
Performance of a novel Next Generation Sequencing circulating tumor DNA (ctDNA) platform for the evaluation of samples from patients with metastatic breast cancer (MBC)
Lorenzo Gerratana et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2020)
Early ctDNA dynamics as a surrogate for progression-free survival in advanced breast cancer in the BEECH trial
S. Hrebien et al.
ANNALS OF ONCOLOGY (2019)
The clinical use of circulating tumor cells (CTCs) enumeration for staging of metastatic breast cancer (MBC): International expert consensus paper
Massimo Cristofanilli et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2019)
Alpelisib for PIK3CA-Mutated, Hormone Receptor-Positive Advanced Breast Cancer
Fabrice Andre et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Emerging Role of Genomics and Cell-Free DNA in Breast Cancer
Lorenzo Gerratana et al.
CURRENT TREATMENT OPTIONS IN ONCOLOGY (2019)
High-intensity sequencing reveals the sources of plasma circulating cell-free DNA variants
Pedram Razavi et al.
NATURE MEDICINE (2019)
Cancer statistics, 2019
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2019)
Circulating tumor DNA analysis in breast cancer: Is it ready for prime-time?
Giuseppe Buono et al.
CANCER TREATMENT REVIEWS (2019)
High-throughput isolation of circulating tumor DNA: a comparison of automated platforms
Lisanne F. van Dessel et al.
MOLECULAR ONCOLOGY (2019)
Blood-based monitoring identifies acquired and targetable driver HER2 mutations in endocrine-resistant metastatic breast cancer
Arielle J. Medford et al.
NPJ PRECISION ONCOLOGY (2019)
Association of a novel circulating tumor DNA next-generating sequencing platform with circulating tumor cells (CTCs) and CTC clusters in metastatic breast cancer
Andrew A. Davis et al.
BREAST CANCER RESEARCH (2019)
Detection of Three Distinct Clonal Populations Using Circulating Cell-Free DNA: A Cautionary Note on the Use of Liquid Biopsy
Gregory M. Riedlinger et al.
JCO PRECISION ONCOLOGY (2019)
The Landscape of Actionable Genomic Alterations in Cell-Free Circulating Tumor DNA from 21,807 Advanced Cancer Patients
Oliver A. Zill et al.
CLINICAL CANCER RESEARCH (2018)
Early circulating tumor DNA dynamics and clonal selection with palbociclib and fulvestrant for breast cancer
Ben O'Leary et al.
NATURE COMMUNICATIONS (2018)
COSMIC: somatic cancer genetics at high-resolution
Simon A. Forbes et al.
NUCLEIC ACIDS RESEARCH (2017)
Neratinib Efficacy and Circulating Tumor DNA Detection of HER2 Mutations in HER2 Nonamplified Metastatic Breast Cancer
Cynthia X. Ma et al.
CLINICAL CANCER RESEARCH (2017)
In patients with metastatic breast cancer the identification of circulating tumor cells in epithelial-to-mesenchymal transition is associated with a poor prognosis
Michela Bulfoni et al.
BREAST CANCER RESEARCH (2016)
Circulating tumor cell thresholds and survival scores in advanced metastatic breast cancer: The observational step of the CirCe01 phase III trial
C. Helissey et al.
CANCER LETTERS (2015)
Analytical and Clinical Validation of a Digital Sequencing Panel for Quantitative, Highly Accurate Evaluation of Cell-Free Circulating Tumor DNA
Richard B. Lanman et al.
PLOS ONE (2015)
Circulating Tumor Cells and Response to Chemotherapy in Metastatic Breast Cancer: SWOG S0500
Jeffrey B. Smerage et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Measures of Outcome in Metastatic Breast Cancer: Insights From a Real-World Scenario
Marta Bonotto et al.
ONCOLOGIST (2014)
Circulating Breast Tumor Cells Exhibit Dynamic Changes in Epithelial and Mesenchymal Composition
Min Yu et al.
SCIENCE (2013)
Metastatic Behavior of Breast Cancer Subtypes
Hagen Kennecke et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Circulating tumor cells, disease progression, and survival in metastatic breast cancer
M Cristofanilli et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Share Paper
